Company news

Zhejiang Starry Pharmaceutical Co., Ltd. Class A (SSE:603520) news

Zhejiang Starry Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Oct 31, 2024: Announcement on "Corporate Value and Return Enhancement" Action…

View Zhejiang Starry Pharmaceutical Co., Ltd. Class A →

Press releases — page 2

Announcement on "Corporate Value and Return Enhancement" Action Plan

October 30, 2024

Announcement on the Completion of Negotiated Transfer Registration for Partial Shares Held by the Controlling Shareholder and Actual Controller

October 21, 2024

← Newer